Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CARE RATING 2021-22 Annual Report Analysis
Fri, 2 Sep

CARE RATING has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

CARE RATING Income Statement Analysis

  • Operating income during the year fell 11.7% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 10.2% YoY during the fiscal. Operating profit margins witnessed a fall and down at 39.2% in FY22 as against 38.5% in FY21.
  • Depreciation charges decreased by 10.4% and finance costs decreased by 35.9% YoY, respectively.
  • Other income declined by 9.4% YoY.
  • Net profit for the year declined by 7.1% YoY.
  • Net profit margins during the year grew from 36.6% in FY21 to 38.5% in FY22.

CARE RATING Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 2,484 2,193 -11.7%
Other income Rs m 313 284 -9.4%
Total Revenues Rs m 2,797 2,476 -11.5%
Gross profit Rs m 958 860 -10.2%
Depreciation Rs m 78 70 -10.4%
Interest Rs m 6 4 -35.9%
Profit before tax Rs m 1,186 1,070 -9.8%
Tax Rs m 277 225 -18.7%
Profit after tax Rs m 910 845 -7.1%
Gross profit margin % 38.5 39.2
Effective tax rate % 23.3 21.0
Net profit margin % 36.6 38.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Revealing on April 30: Are You Ready for the Upcoming Election Surprise?

CARE RATING Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 6 billion as compared to Rs 6 billion in FY21, thereby witnessing an increase of 2.5%.
  • Current assets rose 1% and stood at Rs 11 billion, while fixed assets rose 46% and stood at Rs 2 billion in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 12 billion as against Rs 12 billion during FY21, thereby witnessing a growth of 6%.

CARE RATING Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 5,641 6,424 13.9
 
Current Liabilities Rs m 5,574 5,714 2.5
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 11,751 12,403 5.5
 
Current assets Rs m 10,512 10,592 0.8
Fixed Assets Rs m 1,239 1,811 46.2
Total Assets Rs m 11,751 12,403 5.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



CARE RATING Cash Flow Statement Analysis

  • CARE RATING's cash flow from operating activities (CFO) during FY22 stood at Rs 631 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -225 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs -346 million, an improvement of 20% on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs 61 million from the Rs 48 million net cash flows seen during FY21.

CARE RATING Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 862 631 -26.7%
Cash Flow from Investing Activities Rs m -380 -225 -
Cash Flow from Financing Activities Rs m -434 -346 -
Net Cash Flow Rs m 48 61 27.0%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for CARE RATING

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 28.5, an decline from the EPS of Rs 30.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 515.3, stands at 19.2 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.4 times, while the price to sales ratio stands at 7.0 times.
  • The company's price to cash flow (P/CF) ratio stood at 19.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 84.3 74.0
TTM Earnings per share Rs 30.9 28.5
Diluted earnings per share Rs 30.7 28.5
Price to Cash Flow x 12.3 19.5
TTM P/E ratio x 13.4 19.2
Price / Book Value ratio x 2.3 2.8
Market Cap Rs m 13,023 17,805
Dividends per share (Unadj.) Rs 17.0 17.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for CARE RATING

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.9x during FY22, from 1.9x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 271.2x during FY22, from 193.0x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 13.2% during FY22, from 16.1% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 16.7% during FY22, from 21.1% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 6.8% during FY22, from 7.8% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 1.9 1.9
Debtors’ Days Days 314 226
Interest coverage x 193.0 271.2
Debt to equity ratio x 0.0 0.0
Return on assets % 7.8 6.8
Return on equity % 16.1 13.2
Return on capital employed % 21.1 16.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how CARE RATING has performed over the last 5 years, please visit here.

CARE RATING Share Price Performance

Over the last one year, CARE RATING share price has moved down from Rs 680.6 to Rs 515.3, registering a loss of Rs 165.4 or around 24.3%.

Overall, the S&P BSE SENSEX is up 3.3% over the year.

(To know more, check out historical annual results for CARE RATING and quarterly results for CARE RATING)

Annual Report FAQs

What is the current share price of CARE RATING?

CARE RATING currently trades at Rs 1,175.0 per share. You can check out the latest share price performance of CARE RATING here...

What was the revenue of CARE RATING in FY22? How does it compare to earlier years?

The revenues of CARE RATING stood at Rs 2,476 m in FY22, which was down -11.5% compared to Rs 2,797 m reported in FY21.

CARE RATING's revenue has fallen from Rs 3,582 m in FY18 to Rs 2,476 m in FY22.

Over the past 5 years, the revenue of CARE RATING has grown at a CAGR of -8.8%.

What was the net profit of CARE RATING in FY22? How does it compare to earlier years?

The net profit of CARE RATING stood at Rs 845 m in FY22, which was down -7.1% compared to Rs 910 m reported in FY21.

This compares to a net profit of Rs 835 m in FY20 and a net profit of Rs 1,381 m in FY19.

Over the past 5 years, CARE RATING net profit has grown at a CAGR of -15.1%.

What does the cash flow statement of CARE RATING reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of CARE RATING reveals:

  • Cash flow from operations decreased in FY22 and stood at Rs 631 m as compared to Rs 862 m in FY21.
  • Cash flow from investments increased in FY22 and stood at Rs -225 m as compared to Rs -380 m in FY21.
  • Cash flow from financial activity increased in FY22 and stood at Rs -346 m as compared to Rs -434 m in FY21.

Here's the cash flow statement of CARE RATING for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations1,3381,086674862631
From Investments-246826267-380-225
From Financial Activity-987-1,954-1,070-434-346
Net Cashflow105-42-1284861

What does the Key Ratio analysis of CARE RATING reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of CARE RATING reveals:

  • Operating profit margins witnessed a fall and down at 39.2% in FY22 as against 38.5% in FY21.
  • Net profit margins grew from 36.6% in FY21 to 38.5% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.0 as compared to 0.0 in FY21.

Here's the ratio/financial analysis of CARE RATING for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)63.454.833.438.539.2
Net Profit Margin (%)48.843.334.336.638.5
Debt to Equity Ratio (x)0.00.00.00.00.0

Read: Latest Annual Report Analysis of CARE RATING

Equitymaster requests your view! Post a comment on "CARE RATING 2021-22 Annual Report Analysis". Click here!